Agenda
Applications for consideration at this meeting
- 1372.1 MRI for patients with colorectal carcinoma (CRC) with suspected hepatic metastases or patients with suspected hepatocellular carcinoma (HCC) for the purposes of staging
- 1376.1 70 gene signature (MammaPrint) for use in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
- 1455 Proton Beam Therapy for patients supported under the Medical Treatment Overseas Program
- 1464 Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary
- 1466 Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration
- 1467 Obstetric MRI
- 1468 SIR-Spheres for the treatment of hepatic metastases, and other indications not listed on the MBS
- 1473 A 50 gene signature assay for predicting breast cancer recurrence
- 1475 Ablative fractional laser resurfacing for burn scar treatment
- 1476 Genetic testing for childhood syndromes
- 1483 Micro-bypass stenting for open-angle glaucoma (in trabecular meshwork)
- 1496 Micro-bypass stenting for open-angle glaucoma (external to Schlemm's canal)
Related information
Committee: